Aims: To investigate the changes in the electroencephalographic (EEG) spectrum in smokers during exposure to a neutral and a smoking-related cue to determine whether these EEG changes are still present in ex-smokers after prolonged abstinence and to examine the relationship between the power in each spectral bandwidth and subjective craving. Methods: EEG frequencies in response to a smoking-related and a neutral cue were examined in 23 smokers and 21 ex-smokers, who quit smoking for 1.4 years on average. Additionally, self-report measures of cigarette craving and nicotine dependence were obtained. The spectral power of each bandwidth was computed, log-transformed, and analyzed using a within-subject design. Differences between EEG activity under neutral and smoking conditions were correlated with differences between pre- and postexperimental subjective craving. Results: Increases in reward craving (desire and intention to smoke) were associated with reduced theta activity, whereas increases in withdrawal craving (reduction of negative affect and withdrawal symptoms) were correlated with increases in both delta and higher alpha power. Furthermore, in smokers, but not in ex-smokers, a significant beta power increase was observed between the neutral condition and the smoking condition. Conclusion: Since the beta band is associated with arousal, attention, and alertness, it is suggested that the beta increase in response to the smoking cue might reflect an enhanced allocation of resources to smoking-related stimuli, i.e. a processing bias, which is an important feature of substance abuse. Since ex-smokers do not respond to the smoking cue with beta activity enhancement, we preliminarily conclude that smoking cues do not arouse ex-smokers or capture their attention as much as they do in smokers.

Keywords:
Smoking, Cue reactivity, EEG, Beta power, Craving, Processing bias
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.